Summary
The product Testosterone Cypionate 200mg, manufactured by Olympian Pharmaceutical, underwent independent testing to verify its authenticity and potency. The sample was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Testosterone Cypionate, with a concentration of 201.94 mg/ml, slightly exceeding the labeled claim of 200 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 31 October 2024. While the results confirm accurate dosing, scrutiny of manufacturer-submitted samples remains essential to ensure reliability across different batches. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Testosterone Cypionate 200mg
- Active Ingredient: Testosterone Cypionate
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51760
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification (Labeled): 200 mg/ml
- Measured Concentration: 201.94 mg/ml
Verification Details
Verification URL: https://janoshik.com/tests/51760_G5Z3VBFTP6XL
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the accurate dosing of Testosterone Cypionate in the tested product, with the measured concentration slightly exceeding the label claim. Since Olympian Pharmaceutical submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that Testosterone Cypionate 200mg meets its labeled dosage, with a measured concentration of 201.94 mg/ml. This batch exhibits strong quality control, ensuring potency and reliability. However, continued testing across batches is essential to maintain consistency in future production. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding injectable testosterone products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
